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Abstract
During chemical transmission, the function of synaptic proteins must be coordinated to effi-
ciently release neurotransmitter. Synaptotagmin 2, the Ca2+ sensor for fast, synchronized
neurotransmitter release at the human neuromuscular junction, has recently been implicated
in a dominantly inherited congenital myasthenic syndrome associated with a non-progressive
motor neuropathy. In one family, a proline residue within the C2B Ca2+-binding pocket of
synaptotagmin is replaced by a leucine. The functional significance of this residue has not
been investigated previously. Here we show that in silico modeling predicts disruption of the
C2B Ca2+-binding pocket, and we examine the in vivo effects of the homologous mutation in
Drosophila. When expressed in the absence of native synaptotagmin, this mutation is lethal,
demonstrating for the first time that this residue plays a critical role in synaptotagmin function.
To achieve expression similar to human patients, the mutation is expressed in flies carrying
one copy of the wild type synaptotagmin gene. We now show that Drosophila carrying this
mutation developed neurological and behavioral manifestations similar to those of human
patients and provide insight into the mechanisms underlying these deficits. Our Drosophila
studies support a role for this synaptotagmin point mutation in disease etiology.
Introduction
Understanding the mechanisms mediating information transmission across a chemical syn-
apse is essential to understanding brain function. During synaptic transmission, membranous
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vesicles filled with neurotransmitter must fuse with the presynaptic membrane in response to
Ca2+ influx, thereby releasing the transmitter into the synaptic cleft. The synaptic vesicle pro-
tein, synaptotagmin, is essential for this release [1–3] as it binds the Ca2+ that triggers vesicle
fusion [4–6]. Synaptotagmin has two Ca2+-binding pockets, C2A and C2B [7–9], which have
both been extensively studied for their role in synchronizing vesicle fusion in vivo [4, 6, 10–12]
and in culture [13, 14]. Synaptotagmin 2 is the predominant isoform found at mammalian
neuromuscular junctions [15, 16], and until recently, has never been linked to disease. How-
ever, whole-exome sequencing techniques have now identified point mutations in the human
synaptotagmin 2 (syt2) gene in patients with a disease combining congenital myasthenic syn-
drome and distal motor weakness, suggesting a role for synaptotagmin in neuromuscular dis-
ease [17, 18].
Two independent mutations in the C2B Ca
2+-binding pocket of syt2 have been identified:
one in a United States (US) family and one in a United Kingdom (UK) family. Patients in each
of the two families exhibit a novel neuromuscular syndrome characterized by foot deformities,
fatigable ocular movements, lower limb weakness, and potentiation of tendon reflexes follow-
ing exercise [17, 18]. In nerve conduction studies, all patients exhibited normal sensory
responses. However, motor responses revealed low amplitude compound muscle action poten-
tials (CMAPs) that exhibited significantly less amplitude depression following brief maximum
voluntary contraction [17, 18]. These findings are indicative of a presynaptic deficit of neuro-
muscular junction function.
Interestingly, both familial mutations are located in C2B Ca
2+-binding pocket of syt2 within
the highly conserved “SDPYVK” residue motif [Fig 1, [17, 18]]. The US family possesses an
aspartate 307 (referred to as D2) to alanine substitution within this motif (Fig 1D, first ). As
D2 is one of the well-ordered C2B aspartate residues known to coordinate the binding of Ca
2+
[9, 19, 20] required for triggering neurotransmitter release [4, 11, 14], the function of this resi-
due has been extensively studied. The UK family possesses a proline 308 to leucine substitution
within this motif (Fig 1D, second ). We investigated the anticipated conformational changes
of the proline to leucine (P-L) substitution by modeling this P-L mutation in silico. Simulation
of the P-L mutation predicts that replacement of the highly conserved proline residue by a leu-
cine would extend β-strand 3 into the Ca2+-binding pocket (Fig 1A and 1B small arrow). The
extension of β-strand 3 is accompanied by a significant distortion of the backbone angles of
residues on the amino terminal side of the proline (S1 Fig). The distortion of upstream resi-
dues places this critical D2 Ca2+-binding residue in a non-ideal conformation for Ca2+ binding
(Fig 1C curved arrow, S1 Fig). Further, the additional amide proton from the mutant leucine
residue forms a new H-bond with neighboring residues in loop 2 (not shown), thereby altering
the shape, and likely the flexibility, of the Ca2+-binding pocket. A more rigid Ca2+-binding
pocket, as well as the sub-optimally positioned D2 Ca2+-binding residue, predict deficiencies
in Ca2+ binding in the P-L mutation. Together, our modeling predicts that this mutation
would result in conformational changes in synaptotagmin’s C2B domain that would impair
Ca2+ binding. Although this proline residue is highly conserved (Fig 1D), its importance for
synaptotagmin function has not been investigated previously.
To directly assess whether the sytP-L point mutation impacts Ca2+-binding resulting in syn-
aptic deficits in vivo, we generated a homologous P-L mutation in the synaptotagmin isoform
expressed at the Drosophila neuromuscular junction (sytP-L). In mammals, the synaptotagmin
1 gene (syt1) is predominantly expressed throughout the cerebral hemispheres while syt2 is
predominantly expressed in the brainstem and spinal cord, and hence at the neuromuscular
junction [15, 16]. There is no syt2 gene in Drosophila [21, 22]; the syt1 gene is expressed pan-
neuronally [23, 24] and codes for the Ca2+ sensor for fast, synchronous neurotransmitter
release [4, 5] throughout the nervous system. When the sytP-L mutation is expressed in
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Drosophila in the absence of wild type synaptotagmin, it results in lethality, demonstrating that
this proline residue is critical for synaptotagmin function. As the human condition presents as
a syt heterozygous dominant disorder, with patients carrying one copy of the wild type syt
gene and one copy of the mutated syt gene (sytWT/sytP-L), we simulated this expression pattern
by driving pan-neuronal expression from one mutant transgene using elavGal4 in syt heterozy-
gotes (+/-;P[sytP-L]/+). Physiologically, mutant larvae exhibit decreased evoked transmitter
release and less synaptic depression during high-frequency stimulus trains, consistent with the
human electrophysiological deficits. In addition, the decreased Ca2+ affinity of release and the
associated decreased release probability documented here are consistent with the predicted
disruption to the C2B Ca
2+-binding pocket (Fig 1A–1C). Behaviorally, mutant adult flies
exhibit less overall activity and a marked increase in fatigability, also consistent with the
human phenotype. Together, these results indicate that this proline to leucine substitution
impairs Ca2+ binding and support a role for this substitution in the etiology of this human neu-
romuscular disease.
Fig 1. Predicted conformational changes in synaptotagmin’s C2B Ca2+-binding pocket. (A) Molecular model
depicting the crystal structure of the synaptotagmin C2B Ca2+-binding pocket. Flexible loops 1, 2, and 3 are indicated.
The proline residue under investigation (P) and the adjacent, Ca2+-coordinating aspartate (D2) are shown as stick
models. Note that the proline is at one end of β-strand 3 (small arrow) and the aspartate is in loop 1. (B) Predicted
structural changes induced by the sytP-L substitution. The leucine (L) and the adjacent aspartate (D2) residues are
shown as stick models and both are now within β-strand 3 (small arrow indicates extension of β-strand 3). The large
arrow indicates a newly-formed β-strand. (C) Overlay of wild type (yellow) and sytP-L mutant (turquoise). The curved
arrow indicates the displacement of the D2 Ca2+-binding residue. (D) Sequence alignment of the highly conserved
SDPYVK amino acid motif of the synaptotagmin C2B domain from humans, rat, zebra fish, squid, Drosophila, and C.
elegans. * locations of the point mutations in the US and UK families, respectively. Note: syt1 and syt2 in mammals
are identical in this region.
https://doi.org/10.1371/journal.pone.0184817.g001
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Results
In the absence of wild type synaptotagmin, the P[sytP-L] mutation
increases the lethality rate
To assess the effects of the sytP-L mutation in the absence of the wild type protein, we drove
pan-neuronal expression of syt transgenes in the sytnull background using the elavGal4 pro-
moter (referred to as -/-;P[sytWT]/+ or -/-;P[sytP-L]/+, see methods for full genotype). Rates of
survival to the first instar larval stage were also compared to larvae lacking any synaptotagmin
1 expression (-/-). Balancer chromosomes used in our crossing scheme result in embryonic
lethality for any wild type synaptotagmin homozygotes (+/+ for syt, included in Table 1 under
unhatched) due to the presence of a homozygous lethal Cy mutation (see methods and S2 Fig)
with an expected frequency of ~25%.
Table 1 depicts percentages and raw counts (in parentheses) of first instar larvae in the
sytnull (-/-, top row) and syt heterozygous (+/-, second row) backgrounds and embryonic lethal-
ity (unhatched) of progeny containing one copy of synaptotagmin transgenes (P[sytWT] or
P[sytP-L]) or of progeny containing no transgenic syt (last column). All crosses were carried
out using the CyO second chromosome balancer such that syt homozygotes are lethal (in-
cluded in unhatched) due to the presence of the homozygous lethal Cy mutation (sytWT Cy/
sytWT Cy). There was a significant decrease in the percentage of first instars expressing one
copy of P[sytP-L] in the absence of any wild type synaptotagmin (-/-;P[sytP-L]/+, 12.0%) com-
pared to control (-/-;P[sytWT]/+, 25.7%, p < 0.0001, Chi-squared test). There was also a signifi-
cant decrease in the percentage of first instars expressing one copy of the P[sytP-L] transgene
(-/-;P[sytP-L]/+, 12.0%) compared to no synaptotagmin expression at all (-/-; no transgenic syt,
18.0%, p< 0.0001, Chi-squared test).
As expected for a fully functional protein, the wild type transgenic cross resulted in progeny
where ~25% were sytnull mutants expressing synaptotagmin from the wild type transgene (-/-;
P[sytWT]/+; Table 1, 25.7%). This is significantly larger than in the P[sytP-L] cross, in which
only 12.0% of progeny were sytnull mutants expressing the mutated transgene (-/-;P[sytP-L]/+,
Table 1, 12.0%, p < 0.0001). As previously shown, sytnull mutants are viable [25], and the cross
lacking any source of synaptotagmin resulted in 18.0% of progeny that were sytnull mutants
(Table 1, no transgenic syt, 18.0%). Yet the expression of the mutant transgene resulted in a
significant decrease in the rate of survival to the 1st instar larval stage (Table 1, 18.0% down to
12.0%, p< 0.0001). Thus, in the absence of wild type synaptotagmin, the expression of P
[sytP-L] not only fails to rescue synaptotagmin function, it results in a negative impact on sur-
vival. This is the first study to show the critical nature of this proline residue for synaptotagmin
function.
Transgenic synaptotagmin is expressed appropriately
To verify appropriate transgenic synaptotagmin expression levels for modeling this disease in
Drosophila, western blot analysis was performed on the central nervous system (CNS) of lar-
vae. Comparison of CNS samples from syt heterozygotes (+/-) and syt heterozygotes expressing
Table 1. The syt P-L mutation negatively impacts survival rate in the absence of native synaptotagmin.
P[sytWT] P[sytP-L] No transgenic syt
-/- 25.7% (365) 12.0% (212) 18.0% (231)
+/- 48.7% (691) 50.1% (888) 49.8% (640)
Unhatched 25.6% (363) 37.9% (671) 32.2% (415)
https://doi.org/10.1371/journal.pone.0184817.t001
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one copy of the mutant transgene (+/-; P[sytP-L]/+, hereafter referred to as P[sytP-L] heterozy-
gotes) showed significant differences in the level of synaptotagmin expression with an approxi-
mate doubling of synaptotagmin levels in the transgenic line (Fig 2A, +/- is 46 ± 18% of +/-;
P[sytP-L]/+, p = 0.0008). This finding indicates approximately equal protein expression from
the native gene and the transgene. Consistent with this interpretation, CNS samples from wild
type syt homozygotes (+/+) and from P[sytP-L] heterozygotes showed similar levels of synapto-
tagmin expression (Fig 2B, +/-;P[sytP-L]/+ is 94 ± 9.0% of +/+, p = 0.69). Fig 2C demonstrates
approximately equal levels of synaptotagmin in P[sytP-L] heterozygotes and the P[sytWT] het-
erozygous controls (+/-; P[sytP-L]/+ is 121 ± 8.1% of +/-;P[sytWT]/+, p = 0.25). Thus, our het-
erozygous transgenic control also expresses appropriate levels of synaptotagmin. Finally, both
Fig 2. Transgenic synaptotagmin is expressed at appropriate levels and exhibits appropriate
localization. (A-C) Representative western blots above and average synaptotagmin expression normalized
to actin levels below. Syt heterozygotes expressing one copy of the mutant transgene (+/-;P[sytP-L]/+, n = 6, 5,
and 7, respectively) are compared to syt heterozygotes (+/-, n = 5, A), syt homozygotes (+/+, n = 5, B), and syt
heterozygotes expressing one copy of the wild type transgene (+/-; P[sytWT]/+, n = 8, C). The P[sytP-L]
heterozygotes had approximately twice as much synaptotagmin expression as syt heterozygotes (p = 0.0008,
student t-test), while there was no significant difference in expression between the other lines compared (Fig
2B, p = 0.69 and Fig 2C, p = 0.25). Error bars depict SEM. (D, E) Third instar larvae stained with antibodies
against horseradish peroxidase (HRP) as a general axonal stain (red) and synaptotagmin (green). Scale bars
represent 10 μm. (F, G) First instar larvae stained with antibodies against synaptotagmin. Scale bars
represent 20 μm.
https://doi.org/10.1371/journal.pone.0184817.g002
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the transgenic wild type and transgenic mutant protein are appropriately targeted to the syn-
apse (Fig 2D–2G). As seen in wild type Drosophila [23, 24], synaptotagmin staining in muscles
is restricted to the neuromuscular junction in third instar larvae of both the P[sytWT] heterozy-
gote controls and the P[sytP-L] heterozygotes (Fig 2D and 2E, respectively). Staining of first
instar larvae expressing the syt transgenes in the absence of native synaptotagmin also revealed
that the transgene is appropriately expressed at the neuromuscular junction (Fig 2F and 2G,
-/-;P[sytWT]/+ and -/-; P[sytP-L]/+).
Lifespan is decreased in P[sytP-L] heterozygotes
While P[sytP-L] heterozygotes are easily generated and maintained throughout all larval and
adult stages, we wanted to ascertain whether this mutation had any impact on lifespan in het-
erozygotes. Therefore, we performed a longevity assay. Lifespans between P[sytWT] heterozy-
gotes (51.4 ± 1.50 days, mean lifespan ± SEM, n = 151) and P[sytP-L] heterozygotes (39.2 ± 1.25
days, mean lifespan ± SEM, n = 149) are significantly different (Fig 3, p< 0.0001, Wilcoxon
Rank-Sum test). However, this does not relate directly to the human condition, who show no
indication of this P-L mutation impacting longevity, as these flies do not receive any medical
intervention. These results support a detrimental role of the proline to leucine mutation in
survival.
The sytP-L mutation disrupts evoked transmitter release
In human motor nerve conduction studies, the summated response of all muscle fibers sup-
plied by a particular motor nerve can be measured as a CMAP. The sytP-L-affected family
members present with decreased CMAP amplitudes [17, 18], consistent with a decrease in
evoked transmitter release. To test evoked release in Drosophila P[sytP-L] heterozygotes, we
measured excitatory junction potentials (EJPs) at the larval neuromuscular junction. Upon
nerve stimulation, P[sytP-L] heterozygotes exhibited a significant decrease in the amount of
Fig 3. Lifespan is decreased in P[sytP-L] heterozygotes. (A) Adult lifespan curves of +/-;P[sytWT]/+
(n = 151, black) and +/-;P[sytP-L]/+ (n = 149, red). (B) Mean lifespan is significantly decreased in +/-;P[sytP-L]/+
adults (p < 0.0001, Wilcoxon Rank-Sum test).
https://doi.org/10.1371/journal.pone.0184817.g003
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neurotransmitter released (Fig 4A and 4B). Average EJP ± SEM for +/-;P[sytWT]/+ was
34.8 ± 0.83 mV, and for +/-;P[sytP-L]/+ was 29.6 ± 1.5 mV (p = 0.002, student t-test). This
decrease in release is consistent with the decrease in baseline amplitude in the human motor
nerve conduction studies.
One potential explanation for this observed 20% decrease in evoked response could be a
decrease in quantal content. To determine quantal size, we calculated the mean amplitudes of
Ca2+-independent spontaneous miniature EJPs (mEJPs) in both P[sytP-L] heterozygotes and
their controls. Each mEJP results from one vesicle fusing with the presynaptic membrane. Thus,
the amplitude of the response is an indication of the amount of neurotransmitter loaded into
each vesicle. Neither the mean amplitude nor frequency of mEJPs in controls and P[sytP-L] het-
erozygotes were significantly different (Fig 4C–4E). Mean mEJP amplitude ± SEM for P[sytWT]
heterozygotes was 0.96 ± 0.03 mV (n = 50 mEJP events from 19 fibers), and for P[sytP-L] hetero-
zygotes was 1.06 ± 0.05 mV (n = 50 mEJP events from 12 fibers, p = 0.09, Wilcoxon Rank-Sum
Test). Mean mEJP frequency ± SEM for P[sytWT] heterozygotes was 1.55 ± 0.15 Hz (n = 19
Fig 4. Synchronous evoked release is impaired in P[sytP-L] heterozygotes, but quantal content is
unchanged. (A) Representative EJP traces for control and P[sytP-L] heterozygotes. Scale bars represent 10
mV, 0.2 s. (B) Mean EJP amplitude is significantly less in P[sytP-L] heterozygotes (n = 19) compared to control
(n = 12, *p = 0.002). Error bars depict SEM. (C) Representative consecutive 3 second mEJP traces for control
and P[sytP-L] heterozygotes. Scale bars represent 1 mV, 0.2 s. (D, E) Neither mean mEJP amplitude
(p = 0.09, Wilcoxon Rank-Sum Test, D) nor mean mEJP frequency (p = 0.18, student t-test, E) is significantly
different between P[sytP-L] heterozygotes (n = 12 fibers) and control (n = 19 fibers). Error bars depict SEM.
https://doi.org/10.1371/journal.pone.0184817.g004
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fibers), and for P[sytP-L] heterozygotes was 1.94 ± 0.26 Hz (n = 12 fibers, p = 0.18, student t-
test). These results demonstrate that the decrease in evoked release is not due to a change in
quantal content.
Transmitter release from an activated nerve terminal is a Ca2+-dependent, cooperative pro-
cess [26]. Evoked release was measured at a variety of extracellular Ca2+ concentrations, rang-
ing from 0.05 mM to 5 mM, to assess whether the Ca2+ dependence of release was altered in P
[sytP-L] heterozygotes. At all Ca2+ concentrations above 0.1 mM, P[sytP-L] heterozygotes exhibit
a decrease in evoked release compared to controls (Fig 5A). A nonlinear regression analysis
determined a change in the Ca2+ dependence of P[sytP-L] heterozygotes. The extracellular Ca2+
concentration at which a 50% maximum response is reached (EC50) is statistically shifted in
P[sytP-L] heterozygotes compared to controls. In +/-;P[sytWT]/+ EC50 = 0.33 mM Ca2+ (95%
confidence intervals from 0.30–0.36 mM Ca2+) and in +/-;P[sytP-L]/+ EC50 = 0.44 mM Ca2+
(95% confidence intervals from 0.41–0.48 mM Ca2+, Fig 5B). The non-overlapping confidence
intervals demonstrate that the proline to leucine substitution in synaptotagmin results in a sig-
nificant decrease in the Ca2+ affinity of release.
Release probability is decreased in P[sytP-L] heterozygotes
A decrease in the size of the readily releasable pool and/or a decrease in release probability for
individual vesicles could result in decreased evoked transmitter release. To determine whether
P[sytP-L] heterozygotes exhibit alterations in the size of their readily releasable pool of synaptic
vesicles, we triggered Ca2+-independent vesicle fusion events using a hypertonic solution
(0.5 M sucrose). Before sucrose stimulation, mEJP frequency is similar between both P[sytWT]
and P[sytP-L] heterozygotes [Fig 5C filled symbols, +/-;P[sytWT]/+ (black), 1.95 ± 0.07 Hz and
+/-;P[sytP-L]/+ (red), 1.81 ± 0.10 Hz, mean mEJP frequency ± SEM, n = 11 fibers for both geno-
types, p = 0.28, student t-test). Increases in mEJP frequencies are observed in both controls
(p< 0.0001, student t-test) and P[sytP-L] heterozygotes (p< 0.0001, student t-test) upon su-
crose stimulation. These mEJP frequencies are also similar between genotypes during the
maximum sucrose response period (Fig 5C filled symbols, +/-;P[sytWT]/+, 5.62 ± 0.23 Hz and
+/-;P[sytP-L]/+, 5.32 ± 0.23 Hz, mean mEJP frequency ± SEM, p = 0.23, student t-test). When
HL3.1 solution is puff applied, mEJP frequency remains similar between P[sytWT] and P[sytP-L]
heterozygotes (Fig 5C open symbols, +/-;P[sytWT]/+, 1.71 ±.0.10 Hz and +/-;P[sytP-L]/+ =
1.96 ± 0.10 Hz, mean mEJP frequency ± SEM, p = 0.23, student t-test, n = 11 for both geno-
types). Moreover, no increase is observed for either genotype during or after saline stimula-
tion (Fig 5C, open circles, +/-;P[sytWT]/+ p = 0.57 and +/-;P[sytP-L]/+ p = 0.83, student t-test),
indicating the increases in mEJP frequencies observed during sucrose stimulation result
from hypertonic solution directly, and not a mechanical stimulation due to the puff ap-
plication. Thus, the size of the readily releasable pool is not significantly altered in P[sytP-L]
heterozygotes.
To address release probability, we used a paired-pulse analysis examining the ratio of the
second response divided by the first response using a 20 msec interpulse interval. P[sytWT]
heterozygotes (n = 18) and P[sytP-L] heterozygotes (n = 24) result in significantly different
paired pulse ratios [Fig 5D, +/-;P[sytWT]/+ = 1.02 ± 0.02 (first pulse = 34.4 ± 0.84 mV, second
pulse = 35.2 ± 0.89 mV, EJP amplitude ± SEM), compared to +/-;P[sytP-L]/+ = 1.27 ± 0.06 (first
pulse = 25.1 ± 1.02 mV, second pulse = 30.6 ± 0.84 mV, EJP amplitude ± SEM), p = 0.0008, stu-
dent t-test]. The significantly larger paired pulse ratio indicates a decrease in release probabil-
ity in P[sytP-L] heterozygotes. Thus, our electrophysiological analysis of P[sytP-L] heterozygotes
indicates the decrease in evoked transmitter release is not due to changes in the readily releas-
able pool, but rather results from a decrease in vesicular release probability.
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Fig 5. The P[sytP-L] mutation decreases the Ca2+ affinity of release and vesicular release probability, but the readily releasable pool is
unchanged. (A) Mean EJP amplitudes from +/-;P[sytWT]/+ (filled black circles) and +/-;P[sytP-L]/+ (filled red circles) larvae at Ca2+ levels ranging from
0.05 mM—5.0 mM. At Ca2+ concentrations above 0.1 mM, statistical differences are seen between the two genotypes (*p < 0.05 for indicated Ca2+
concentrations, see S1 Table for specific n’s and p-values, student t-tests). Lines of best fit were determined using non-linear regression analyses. (B)
Graph depicting normalized EJP responses at log Ca2+ concentrations. EC50 values were determined using the line of best fit determined by nonlinear
regression analyses. Dotted lines depict the shift in the EC50 value. (C) Application of hypertonic 0.5 M sucrose to +/-;P[sytWT]/+ (n = 11 fibers, filled
black circles) and +/-;P[sytP-L]/+ (n = 11 fibers, filled red circles) results in increases in mEJP frequency. Black bar below the traces represents the
duration of the 10 second application of 0.5 M sucrose or saline solution. Black bars above the mEJP responses indicate three consecutive seconds of
individual traces either before sucrose application (left inset) or during peak sucrose response (right inset). Similar frequencies between +/-;P[sytWT]/+
and +/-;P[sytP-L]/+ are observed both before and during sucrose response (n = 11 fibers for both genotypes, p = 0.28 before sucrose application,
p = 0.23 during maximum sucrose response). Application of bath solution does not result in an increase in mEJP frequency in either genotype (open
circles) (p = 0.57 for +/-; P[sytWT]/+ and p = 0.83 for +/-;P[sytP-L]/+, student t-test). Scale bar 2mV, 3s. (D) Paired-pulse analysis indicates a decrease in
release probability in +/-;P[sytP-L]/+. Left, representative traces of responses stimulated with a 20 ms interpulse interval. Scale bar 5 mV, 40 ms. Right,
in P[sytP-L] heterozygotes, the paired pulse ratio is significantly increased (+/-;P[sytWT]/+ = 1.02 ± 0.02, +/-;P[sytP-L]/+ = 1.27 ± 0.06, *p = 0.0008,
student t-test). Error bars are SEM.
https://doi.org/10.1371/journal.pone.0184817.g005
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A distinctive feature of the human condition is that following brief maximal voluntary mus-
cle contraction, the CMAP amplitude is less depressed, typically for several minutes [17, 18].
Since a decrease in release probability could result in less depression, we assessed this unique
phenotype in Drosophila. We measured the amplitude of evoked release at the larval neuro-
muscular junction following a 10 Hz stimulation for 2 seconds. Responses were normalized to
the initial EJP response to account for the decrease in EJP amplitude seen in the P[sytP-L] het-
erozygotes. Beginning at the fourth pulse of this stimulation period, P[sytP-L] heterozygotes
exhibited a significant 5–10% decrease in synaptic depression relative to control (Fig 6, S2
Table). However, when a test stimulation was applied 1 minute after the end of the stimulus
train, this effect was no longer observed; the amplitude of the evoked response in both the P
[sytP-L] heterozygotes and the controls had returned to resting levels (Fig 6, S2 Table).
Since maximum voluntary contraction can produce motor nerve firing rates in excess of 50
Hz [27], larval preparations were stimulated at 50 Hz for 2 seconds in an attempt to more
closely approximate the stimulus that results in the prolonged increase in release seen in the
affected family members. Normalized post-stimulus train responses were tested at 1 second
and then at 30-second intervals out to 4 minutes. This protocol displayed similar results to the
10 Hz stimulation experiment. Both at the end of the stimulus train and at 1 second post-stim-
ulation, there is no synaptic depression in the P[sytP-L] heterozygotes, unlike in the control
(Fig 7, S3 Table). However, normalized responses to test stimulations at 30 seconds or longer
after cessation of the stimulation train showed no significant differences in release between the
Fig 6. P[sytP-L] heterozygotes exhibit less depression throughout the course of high frequency
stimulation, but fail to maintain this relatively increased response upon cessation of stimulation. (A)
Representative traces from control and P[sytP-L] heterozygotes during a 2 second, 10 Hz stimulation train,
and a single stimulus 1 minute following cessation of the train. Dotted line represents the amplitude of the
initial response. Scale bar represents 10 mV, 0.2 s. (B) Mean EJP amplitudes of P[sytP-L] heterozygotes
(n = 17) showed less depression compared to control (n = 14, *indicates p < 0.05, and **indicates p < 0.001).
However, this relative increase in release is not maintained upon cessation of the stimulus train (p = 0.87).
Error bars depict SEM.
https://doi.org/10.1371/journal.pone.0184817.g006
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P[sytP-L] heterozygotes and controls (Fig 7, S3 Table). Thus, our transgenic model system can-
not provide insight into the prolonged increase of the CMAP amplitude following maximal
voluntary contraction, which can last 10 minutes or longer in humans [17, 18].
Basal levels of locomotor activity are decreased in P[sytP-L]
heterozygotes
The P-L familial condition presents with distal limb deformities, muscle wasting, and difficulty
walking [17, 18]. To assess the impact of this mutation on overall motor function in our model
system, the Drosophila activity-monitoring (DAM) assay was performed to quantify basal loco-
motor activity levels. This assay determines total activity over time. However, as activity levels
in Drosophila males and females are known to have different circadian cycles [28, 29], males
and females were tested separately. Activity level was determined by monitoring individual
flies for 6 days in a 12hr light: 12hr dark cycle (Fig 8A and 8B) in age- and sex-matched adult
Drosophila P[sytWT] or P[sytP-L] heterozygotes.
Drosophila are typically active during periods of light and inactive during periods of dark.
Furthermore, flies have an increase in locomotor activity in anticipation of the transition
between dark to light and light to dark. We analyzed the locomotor activity at the two
Fig 7. The sytP-L mutation does not result in synaptic depression during and shortly after a high frequency
50 Hz stimulation, but this relative increase in release is short-lived. (A) Representative traces for control and
P[sytP-L] heterozygotes showing the initial 2 second 50 Hz train, followed by each post-train pulse at 1 second, then
every 30 seconds thereafter for 4 minutes. Dotted line represents the amplitude of the initial response. Scale bar
represents 10 mV, 0.1 s. (B) Average EJP amplitude during and after 50 Hz stimulation in control (n = 18) and P
[sytP-L] heterozygotes (n = 24). Responses were normalized to the amplitude of the initial response. Unlike controls,
P[sytP-L] heterozygotes do not exhibit synaptic depression at the end of the stimulus train (p << 0.0001) and 1
second after cessation of the train (p = 0.0012). Error bars depict SEM.
https://doi.org/10.1371/journal.pone.0184817.g007
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anticipatory peaks of activity (Active 1 and 2, respectively), the non-peak period during lights
on (Active 3) and the inactive period approximately corresponding to lights off (Inactive). We
find distinct periods of activity between males and females, consistent with published data [28,
29]. During all activity periods, both male and female P[sytP-L] heterozygotes displayed signifi-
cantly less movement (Fig 8C and 8D, S4 Table).
The rate of muscle fatigue is faster in P[sytP-L] heterozygotes
Affected individuals with the human disease also present with cramping and pain upon physi-
cal exertion, difficulty with sports, and some fatigable eye movements [18]. Since these can all
be associated with fatigability in muscle, we analyzed fatigue rate in adult Drosophila using a
modified climbing assay [30]. Flies were repetitively knocked to the bottom of a vial. This stim-
ulates negative geotaxis, an innate escape response in which flies climb up the vial wall. Vials
were dropped (see methods) every 10 seconds for 30 minutes. After each drop, the distance
Fig 8. The sytP-L mutation affects locomotor activity in Drosophila. (A, B) Average activity per 30 minutes for an averaged 24-hour day in a
6-day Drosophila Activity Monitoring Assay in 5–7 day old females (A) and males (B). (C, D) Distinct activity periods (AP) were averaged for
females (C, n = 48 for each genotype) and males (D, n = 48 for +/-;P[sytP-L]/+, n = 45 for control). P[sytP-L] heterozygotes were significantly less
active than controls during all activity periods in both males and females (* indicates p < 0.001, student t-tests). Error bars depict SEM.
https://doi.org/10.1371/journal.pone.0184817.g008
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each fly climbed upward within 5 seconds was measured and averaged. As with the DAM
assay, we tested age-matched female and male adult flies separately. Differences were observed
as early as the first drop for both males and females of P[sytP-L] heterozygotes and controls
(female +/-;P[sytWT]/+ = 6.49 ± 0.60 cm, female +/-;P[sytP-L]/+ = 3.67 ± 0.91 cm, p = 0.017, stu-
dent t-test, male +/-;P[sytWT]/+ = 6.99 ± 0.45 cm, and male +/-;P[sytP-L]/+ = 4.68 ± 0.64 cm,
p = 0.009, student t-test, average distance traveled ± SEM after the first drop). To specifically
measure fatigue, we controlled for the decreased overall activity in the mutants by normalizing
all measurements to the distance traveled after the initial drop. The normalized data was then
graphed over time for both females and males (Fig 9A and 9B, respectively). As a measure of
the rate of fatigue, we calculated the log of the raw data and used linear regressions to provide
predicted lines of best fit (not shown). The slopes of these lines were statistically significantly
different between mutants and controls in both females and males (slopes for female +/-;P
[sytWT]/+ = -0.013, female +/-;P[sytP-L]/+ = -0.039, male +/-;P[sytWT]/+ = -0.011, and male +/-;
P[sytP-L]/+ = -0.069, p< 0.0001 for both females and males, see methods). These results dem-
onstrate a faster rate of fatigue in the P[sytP-L] heterozygotes, consistent with the muscle fatiga-
bility seen in the affected family members.
Fig 9. The sytP-L mutation increases the rate of fatigue in Drosophila. (A, B) Normalized values of
distance traveled up a vial wall after repetitive drops over time for 5–7 day old females (A) and males (B).
Each point is a binned 1 minute average of 6 drops (1 drop every 10 seconds) normalized to the percentage of
the distance traveled after the first drop. Statistical analysis indicates different rates of fatigue (see methods)
between the two genotypes for both females (p < 0.0001) and males (p < 0.0001), indicating the P[sytP-L]
heterozygotes (n = 10) fatigued significantly faster than controls (n = 10).
https://doi.org/10.1371/journal.pone.0184817.g009
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Discussion
In this study we have investigated a synaptotagmin point mutation that was implicated in the
etiology of a congenital myasthenic syndrome found in a single family. By modeling this point
mutation in silico, we predict significant conformation changes to a key, well-ordered Ca2+-
binding residue essential for fast, synchronous neurotransmitter release. The role of this con-
served proline residue in these C2 domains could be to punctuate the end of the β-strand
leading into the Ca2+-binding pocket thereby providing maximum Ca2+ binding volume opti-
mizing Ca2+ sensitivity.
We expressed the homologous mutation in Drosophila and documented several similar def-
icits to those seen in the affected patients. In addition, we found a decreased Ca2+ affinity for
release and decreased release probability that are consistent with the conformational changes
predicted by our in silico analysis. Notably, this sytP-L mutation not only fails to rescue synapto-
tagmin function, it has a negative impact on survival when expressed as the sole source of
synaptotagmin (-/-;P[sytP-L]/+); the survival rate is significantly lower than that of larvae with
no synaptotagmin expression (-/-). This finding demonstrates for the first time that this pro-
line residue in the C2B Ca
2+-binding pocket is essential for synaptotagmin’s Ca2+-sensing
function. By driving expression of the mutant transgene in syt heterozygotes (+/-;P[sytP-L]/+),
we were able to achieve expression levels of sytWT and sytP-L similar to that in the human
disease.
Electrophysiological analyses demonstrated deficits that may help inform the human condi-
tion. Consistent with the human nerve conduction tests, the EJP amplitude at the larval neuro-
muscular junction in P[sytP-L] heterozygotes is significantly decreased. This decrease in the
initial evoked response is not due to a decrease in quantal size or the readily releasable pool. P
[sytP-L] heterozygotes exhibit a decreased Ca2+ affinity, as documented by the increased EC50
for Ca2+, which resulted in a decreased release probability, as documented by the facilitated
responses in paired pulse experiments, and either no, or less, depression during high frequency
stimulations. This decreased probability of release could account for an increased failure rate
at the neuromuscular junction, consistent with the decreased CMAP seen in humans.
The P[sytP-L] mutation resulted in significant electrophysiological deficits when expressed
in a heterozygous background. This is notable, as synaptotagmin heterozygotes previously
have been shown to exhibit no significant changes in electrophysiological responses compared
to synaptotagmin homozygotes [31]. Although we did not express this mutation in an other-
wise wild type background, this would be consistent with a dominant negative phenotype.
This proline to leucine mutation presents with behavioral deficits similar to those in
patients, most notably decreased movement and increased fatigability. This similarity of multi-
ple deficits found in the familial disease strongly supports a role for this residue in the etiology
of this form of congenital myasthenic syndrome. It is only recently that mutations in the syt1
and syt2 genes have been implicated in human disease [17, 18, 32]. A patient with a de novo
mutation in the human syt1 gene presented with an early onset dyskinetic movement disorder,
severe motor delay, and profound cognitive deficits attributed to a single amino acid substitu-
tion in the C2B Ca
2+-binding pocket: an isoleucine to threonine (I-T) substitution [32]. This
hydrophobic isoleucine residue had been shown previously to mediate Ca2+-dependent mem-
brane penetration by synaptotagmin [33–36]: an effector interaction critical for coupling Ca2+
influx with neurotransmitter release from neurons [37, 38]. Since this syt mutation results in
the most severe deficits in an animal system [37] and is located in the syt1 gene, which is pref-
erentially expressed in the cerebral hemispheres [15, 16], it is not surprising that this patient
experienced extreme cognitive deficits as well as the most severe motor deficits observed in a
synaptotagmin human disease to date [32].
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Herrmann et al, 2014 reported two mutations in the human syt2 gene implicated in the eti-
ology of congenital myasthenic syndrome patients: the proline to leucine (sytP-L) mutation
analyzed in this paper and an adjacent aspartate to alanine (sytD-A) mutation. Both of these
highly conserved residues are located in synaptotagmin’s C2B Ca
2+-binding pocket [9, 19, 39].
While the function of this proline residue had not been previously studied in animal models,
previous studies have demonstrated that the Ca2+-binding aspartate residues of the C2B
domain are essential for synaptotagmin function [4, 14, 17, 35], at times resulting in lethality
in animal models [4, 17]. The single viable Drosophila line from our lab investigating C2B
aspartate mutations had somewhat reduced expression of the mutant transgene [4]. Since
these mutations result in a dominant negative decrease in evoked transmitter release (worse
than no synaptotagmin at all) [4], the decreased expression level in our line may have contrib-
uted to its viability. When driven in the presence of native synaptotagmin, our Drosophila lines
that disrupted Ca2+ binding by C2B were viable, but they did result in a significant dominant
negative knockdown in function [4]. For the sytD-A familial mutation, expression of the mutant
syt from a transgene in syt heterozygotes resulted in lethality in 4 of 6 independent transgenic
lines. There was a dramatic decrease in the evoked response in the remaining two lines [17].
The sytP-L mutation investigated here, however, resulted in no viability issues in the heterozy-
gous background, and only a 20% decrease in the evoked response. Thus, it is surprising that
both the sytP-L and the sytD-A human families present with such similar symptoms [17, 18].
Given the severe consequences of mutating the C2B Ca
2+-binding aspartate residues in animal
models, it is noteworthy that the deficits seen in the affected human family are comparatively
mild [17, 18].
It has been shown that Ca2+-binding by the aspartate residues [9, 19, 35] as well as mem-
brane penetration by the hydrophobic residue [33–36], both located in the C2B domain of
synaptotagmin, are of critical importance for proper synchronous transmitter release [4, 14,
17, 18, 32, 37]. Interestingly, the proline residue investigated in this study is located directly
adjacent to one of these aspartates residues. We speculate that this proline residue may provide
conformational rigidity important for stabilizing the C2B Ca
2+-binding pocket. By mutating
the proline to a leucine, the rigid R group found in the proline residue would be lost, poten-
tially affecting the precise conformation of the pocket and impacting the ability of the adjacent
aspartate to bind Ca2+. Such a mechanism could result in a decreased, albeit not demolished,
ability of the C2B domain to bind Ca
2+, resulting in the less severe phenotype documented
here compared to both the aspartate and isoleucine mutations in vivo [4, 11, 17, 18, 32, 37].
In our Drosophila P[sytP-L] heterozygotes, the impact of high frequency stimulation on EJP
amplitude was short-lived. Thus our model system cannot provide insight into the long-lasting
decrease in depression of the CMAP seen in the human patients following maximal voluntary
contraction. The initial facilitation and following lack of depression observed in our P[sytP-L]
heterozygotes during and immediately after high frequency stimulation is predicted by the
residual Ca2+ hypothesis for short-term plasticity [40–42]. The increase in paired pulse facilita-
tion (Fig 5D) and lack of depression observed during high frequency stimulation (Figs 6 and
7) demonstrate that the sytP-L mutation decreased release probability compared to wild type.
Accordingly, the build-up of Ca2+ that occurs during high-frequency stimulation is predicted
to contribute to a relatively increased release probability during and shortly after the stimulus
train. As this sytP-L mutation is predicted to disrupt the critical C2B Ca2+-binding pocket of
synaptotagmin (Fig 1A–1C), which is the Ca2+ sensor for fast, synchronous neurotransmitter
release, a decrease in release probability was not unexpected. The note-worthy long-lasting
potentiation of the CMAP, which can last up to 60 minutes in human sytP-L patients [18]
remains unexplained; mutation of the Ca2+ sensor would not be predicted to cause such a
long-lasting effect.
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The decreasing cost and increasing availability of DNA sequencing has led to an increased
incidence of genomic sequencing during patient diagnoses. This ever-increasing process will
undoubtedly lead to the discovery of additional synaptic mutations and associated genetic dis-
orders. The need for a relatively quick and cost effective method to begin elucidating the
molecular mechanisms underlying these synaptic disorders is vital. Using Drosophila to model
these newly discovered conditions in highly conserved pathways like synaptic transmission is
ideal for elucidating their underlying mechanisms, as Drosophila provide a cost-effective and
rapid mechanism for analysis.
In summary, we have identified the functional role of a predicted leucine-induced con-
formational change in the C2B Ca
2+-binding pocket of synaptotagmin. Expression of the
homologous human mutation in Drosophila resulted in deficits similar to many of the human
symptoms. Thus, this work supports a role for this synaptotagmin point mutation in disease
etiology and elucidates the molecular mechanisms responsible.
Materials and methods
Mutagenesis
In Drosophila, the syt1 gene is expressed in all neurons [23, 24] and is homologous to both syt1
and syt2 in mammals [21]. Proline residue 363 of Drosophila syt1 is homologous to proline 308
in human syt2, implicated in the human disease, and proline 310 in rat syt1, modeled in Fig 1.
Using the Drosophila syt1 coding sequence [43, 44], both a wild type control and a P363L
mutant cDNA flanked by EcoRI and BglII restriction sites were synthesized by GeneWiz (La
Jolla, CA). The synthesized cDNAs were then subcloned into the PUAST-attB vector to place
the transgenes under the control of the UAS promoter and the PhiC31 targeted insertion sys-
tem was used to target the transgene containing vectors to the attP2 landing site on the Dro-
sophila third chromosome [BestGene, Chino Hills, CA; [45, 46]]. We refer to the mutant
transgene as P[sytP-L] and the control transgene as P[sytWT].
Fly lines
Expression of the UAS-driven syt transgenes was localized to the nervous system using a pan-
neuronal source of GAL4 [elavGAL4 [47, 48]]. SytAD4 was the sytnull mutation used [44].
Synaptotagmin is found natively on the second chromosome, and the syt transgene used was
incorporated into a third chromosome landing site. To directly assess the function of the sytP-L
mutation, the impact of transgene expression on survival was assessed in the sytnull back-
ground. For these experiments, the following genotype yw;sytnullP[elavGal4w+]/CyO,GFPw+
was crossed to yw;sytnull/CyO,GFP;P[UASsytWT,y+w+] or yw;sytnull/CyO,GFP;P[UASsytP-L y+
w+] or yw;sytnull/CyO,GFP to generate: 1) the transgenic control in the sytnull background yw;
sytnullP[elavGAL4w+]/sytnull;P[UASsytWTy+w+]/+ (referred to as -/-; P[sytWT]/+), 2) the trans-
genic mutant in the sytnull background, yw;sytnullP[elavGAL4w+]/sytnull;P[UASsytP-Ly+w+]/+
(referred to as -/-;P[sytP-L]/+), and 3) sytnull mutants, yw; sytnullP[elavGAL4w+]/sytnull (referred
to as -/-), respectively. Expression of the mutant transgene resulted in embryonic or first instar
lethality. Therefore, for most experiments, the P[sytP-L] transgene was expressed in a syt het-
erozygous background in order to mimic the heterozygous nature of the affected human
population (sytP-L/sytWT). This results in synaptotagmin expression from a single copy of the
endogenous syt gene and from a single copy of the mutant syt transgene. For these experi-
ments, the following genotype yw;sytnullP[elavGal4w+]/CyO,GFPw+ was crossed to yw;+;P[UAS-
sytP-Ly+w+] or yw;+;P[UASsytWT y+w+] (note: both of these transgenic lines are homozygous
for sytWT on the second chromosome) to generate: 4) the transgenic mutant in the syt hetero-
zygous background, yw; sytnullP[elavGAL4w+]/sytWT;P[UASsytP-Ly+w+]/+ (labeled as +/-;P
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[sytP-L]/+ in the figures and referred to as P[sytP-L] heterozygotes in the text), and 5) the transgenic
control in the syt heterozygous background, yw;sytnullP[elavGAL4w+]/sytWT;P[UASsytWTy+w+]/+
(labeled as +/-;P[sytWT]/+ in the figure legends and referred to as P[sytWT] heterozygotes in the
text). For western analyses, the additional genotypes used for comparisons were: 6) syt heterozy-
gotes, yw; sytnull/sytWT; P[UASsytP-Ly+w+]/+ (labeled as +/- in Fig 2A), and 7) syt homozygotes, yw;
sytWT/sytWT; P[UASsytP-Ly+w+]/+ (labeled as +/+ in Fig 2B). The experimental syt heterozygotes
(+/- in Fig 2A) and homozygotes (+/+ in Fig 2B) both contained the P[sytP-L] transgene but lack
the elavGal4w+ driver, so the transgene was not expressed.
Molecular dynamics
As the crystal structures of mammalian synaptotagmin 2 proteins have not been solved, we
obtained the crystal structures of rat Syt1 C2B (PDB file1TJX) [20] from the Protein Data Bank.
The C2B domains of mammalian synaptotagmin 1 and synaptotagmin 2 are>90% identical (8
substitutions in the core of 93 C2B residues) and most of these substitutions are conservative.
We generated models of the P-L mutation using the mutagenesis wizard in Pymol Molecular
Graphics System, Version 1.8, Schro¨dinger, LLC. The QuikMD utility in NAMD [49] was used
for the simulation. The structures were solvated using the solvate TCL utility in a cube of
approximately 7,000 water molecules (TIP3) with a positive and negative padding of 10 Å on
each axis. Residue 359 in C2B was restrained with harmonic constraints to dampen coordinate
drift within the simulation box. Both wild type and mutant C2B models were simulated using
NAMD [49] with different random seeds for 50,000,000 frames with a time step of two femto-
seconds (total of 100 ns) and a write frequency of 25,000. Periodic boundary conditions were
used with PME and a grid spacing of 1.0. We used rigid bonds and constant group pressure
control. The pressure was controlled with a Langevin piston set at 1.01325 bar (atmospheric
pressure). The temperature was controlled at 310 K with Langevin dynamics and a dampening
coefficient of 5 ps-1 was applied to each trajectory. We validated that the trajectories reached
equilibrium by calculating the root mean squared displacements of all atoms in the protein after
alignment over the course of the run. Each unique simulation setup was run three times.
Lethality assay
The only source of synaptotagmin from the native locus (sytWT) in the crosses used to assess the
effect of transgene (P[syt]) expression was located on the CyO,GFP balancer chromosome (see
fly lines section above). Therefore, any progeny that were homozygous for native synaptotagmin
are categorized as unhatched since they are also homozygous for Cy, which is embryonic lethal
(Table 1, S2 Fig). Based on Mendelian genetics, the expected frequency is ~25% (S2 Fig). At
least three bottle crosses using at least 50 virgin females each were fed on molasses plates supple-
mented with a dab of yeast/baby food mixture and were left to mate for two days. A fresh molas-
ses plate dabbed with yeast/baby food mixture was then provided and the flies were allowed to
lay eggs for 6 hours to provide age-matched progeny. A total of 4476 eggs were collected and
observed. First instar progeny were then scored by phenotype, and the number of unhatched
eggs was counted. The plates were observed daily for three consecutive days to control for any
developmental delays. A chi-squared test between the three genotypes was applied to reject the
test of independence. Additional chi-square tests were applied to test for differences between
-/-;P[sytWT]/+ and -/-;P[sytP-L]/+, as well as between -/- and -/-;P[sytP-L]/+.
Immunoblotting
Western analysis of larval CNSs was used to determine relative levels of synaptotagmin expres-
sion. The CNS was isolated from third instars dissected in Ca2+-free HL3.1 containing 70 mM
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NaCl, 5 mM KCl, 4 mM MgCl2, 10mM NaHCO3, 5 mM Trehalose, 115 mM sucrose, 5 mM
HEPES, pH 7.2 [50]. Samples were sonified for 10 pulses using a Branson Sonifier 450 (VWR
Scientific, Westchester, PA) in Laemmli buffer (Bio-Rad, Hercules, CA) containing 5% 2-mer-
captoethanol. The indicated genotype was loaded one CNS per lane. Samples were electro-
phoresed, transferred to Immobilon membranes (Millipore, Bedford, MA), and washed in
blocking solution according as described [31]. Blots were probed overnight at 4˚C with an
anti-synaptotagmin antibody, Dsyt-CL1 [4], diluted 1:2500 and an anti-actin antibody, MAB
1501 (Millipore Bioscience Research Reagents, Billerica, MA), diluted 1:10,000. Actin levels
were used to normalize for equal protein loading. Blots were visualized using an EpiChemi3
Darkroom and Labworks Imaging software (UVP BioImaging, Upland, CA). The synaptotag-
min:actin ratio was determined for each lane, then normalized to the mean synaptotagmin:
actin ratio of all control lanes on an individual blot to allow comparison of signal between mul-
tiple blots. Outliers in total protein loaded (as indicated by actin levels) were not included in
the analysis. Statistical significance for each comparison was determined using a student’s t-
test.
Immunolabeling
For immunolabeling of the neuromuscular junction, third instars of P[sytWT] heterozygotes
and P[sytP-L] heterozygotes were dissected in Ca2+-free HL3.1 saline to expose their body wall
muscles and fixed in phosphate-buffered saline (PBS, 137 mM NaCl, 1.5 mM KH2PO4, 2.7
mM KCl, 8.1 mM Na2HPO4) containing 2% formaldehyde for 1 hour. Whole-mounts were
incubated overnight in Dsyt-CL1 diluted 1:400 in dilution media [PBS with 0.1% Triton, 1%
bovine serum albumin, and 1% normal goat serum (NGS from Jackson ImmunoResearch,
West Grove, PA)], washed in PBST (PBS with 0.1% Triton) for 3 hours, incubated in Alexa
Fluor 488 goat-anti-rabbit antibody (Invitrogen, Carlsbad, CA) diluted 1:400 and Texas Red
anti-HRP (Jackson ImmunoResearch, West Grove, PA) diluted 1:50 in dilution media for 1
hour, washed in PBST for 1 hour, and mounted in Citifluor (Ted Pella, Redding, CA). To label
transgenic synaptotagmin expressed in the sytnull background, the above protocol was applied
to first instars rather than third instars with the following changes: first instars were fixed in
PBS containing 4% formaldehyde for 2 hours and Texas Red anti-HRP was omitted. Neuro-
muscular junctions at the muscle 6/7 junction were imaged for both first and third instars with
a Zeiss 880 light scanning microscope using a 40X objective, and acquired using Zeiss Zen 2.1
acquisition software, version 11,0,3,190.
Longevity assay
Lifespans between +/-;P[sytWT]/+ and +/-;P[sytP-L]/+ were recorded from at least three separate
crosses using at least 50 virgins in each cross. Lenth’s analysis was used to determine adequate
sample size. N = 151 for +/-; P[sytWT]/+ and n = 149 for +/-; P[sytP-L]/+. Ten newly hatched
adult flies/vial were observed/flipped into fresh food every Monday/Wednesday/Friday and
number of living or dead flies were recorded. Flies that were found alive but stuck in the food
were omitted from analysis. Any flies that escaped during flipping were also omitted from
analysis, as there was no way to determine the length of natural life. The Wilcoxon (two-sam-
ple) Rank-Sum test was used to determine significance between genotypes.
Excitatory junction potentials
Third instars were dissected in Ca2+-free HL3.1 saline. EJPs were evoked from muscle fiber 6
of abdominal segments 3 and 4 in HL3.1 containing 1.0 mM Ca2+ using standard techniques
[25, 31, 37]. Intracellular electrodes of 10–25 MO contained 3 parts 2M potassium citrate to 1
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part 3M potassium chloride. The resting membrane potential of each fiber was maintained at
-55 mV by passing no more than 1 nA of current. Nerves were stimulated with a suction elec-
trode filled with HL3.1 containing 1.0 mM Ca2+. All events were collected using an AxoClamp
2B (Molecular Devices, Sunnyvale, CA) amplifier and digitized using a Powerlab 4/35 A/D
converter (ADInstruments, Sydney, Australia). EJPs were recorded in LabChart software
(ADInstruments, Sydney, Australia). For single evoked responses, averages of 10 EJPs collected
at 0.04 Hz were calculated for each individual fiber. Statistical significance was determined
using a student’s t-test. Spontaneous events were identified manually after recordings had
been randomized and blinded to the researcher. Average mEJP amplitudes were determined
from 50 consecutive mEJP events/fiber, taken from consistent time periods across fibers. Sta-
tistical significance for mEJP amplitude was determined by the Wilcoxon Rank-Sum test. Fre-
quency of spontaneous events was determined by manually counting number of mEJP events
during one minute of baseline activity/fiber. Each fiber was analyzed for the same time period
during the recording to eliminate bias.
Ca2+ dependence of release
Individual fibers were bathed in HL3.1 saline containing Ca2+ levels varying from 0.05 mM–
5.0 mM. Each fiber was recorded in at least three different Ca2+ concentrations to be included
in analysis. At each Ca2+ concentration, the mean response of 5 EJPs collected at 0.5 Hz were
calculated. Lines of best fit were calculated using a nonlinear regression analysis, which pro-
vided EC50 values and their confidence intervals for each genotype.
Paired pulse
Experiments were conducted using a 0.02 second delay between stimulations, and averages of
EJP responses were normalized to the first stimulation. Statistical significance was determined
using a student t-test.
High frequency stimulation
Assays to observe depression or facilitation were first assessed by stimulating the nerve at 10
Hz for 2 seconds followed by a test pulse 60 sec post-stimulus train. EJP amplitudes were nor-
malized to that of the first EJP prior to calculating the average response within a genotype. A
repeated measures analysis of variance was used to compare the two genotypes at each stimu-
lus. Post-hoc t-tests were then used to determine significance. To more closely mimic maximal
voluntary contraction at the human neuromuscular junction, another protocol was designed
using 50 Hz stimulation for 2 seconds, followed by test pulses at 1 second post-stimulus train,
and then at 30 second intervals to 4 minutes. Similar statistical methods as above were applied
to determine significant differences between amplitudes at each individual time point.
Hypertonic solution stimulations
A PicoSpritzer III was used to administer a puff application of either 0.5M sucrose or HL3.1
bath solution to the junctional region of muscle fibers 6 at 5 pounds per square inch (psi) for
10 seconds. Hypertonic stimulations were conducted in Ca2+-free HL3.1. mEJP events were
counted manually for all time points analyzed. To determine baseline mEJP frequency, 10 sec-
onds of mEJP events immediately prior to sucrose or HL3.1 application were analyzed. To
determine average mEJP frequency during maximum sucrose stimulation, 15 seconds of mEJP
events were analyzed, beginning 5 seconds into the sucrose or HL3.1 application. Statistical
significance was determined by student t-tests.
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For all electrophysiological experiments, post-hoc Lenth’s analyses were performed to
ensure adequate sample size. If fibers were unable to maintain a physiological potential when
injected with a maximum of 1 nA of current, they were excluded.
Drosophila activity monitoring
The basal locomotor activity of adult Drosophila was assessed using the TriKinetics Locomotor
Activity Monitoring System (Trikinetics, Waltham, MA). Age-matched 5–7 day old adult flies of
the indicated genotypes were loaded into DAM2 Drosophila activity monitors. Males and
females were tested separately to control for sex differences in circadian rhythms [28, 29]. Ani-
mals were placed on a 12hr light: 12hr dark cycle on standard fly food media and activity was
recorded for 7 days using DAM system Acquisition Software. Data from the first day were not
included in the analysis to allow flies to acclimate to their new environment. Activity levels were
binned into 30-minute intervals and uploaded into Microsoft Excel using DAM Filescan soft-
ware. Using these 30-minute intervals, an averaged 24-hour day was created for each genotype
and sex. Four distinct activity periods were determined post-hoc that correspond to Drosophila’s
two anticipatory peaks (Active 1 and 2), a lights-on active period (Active 3), and a lights off-inac-
tive period (Inactive). T-tests were performed to compare genotypes during each activity period
for both males and females. Flies that died during the course of the experiment were excluded
from the analysis. Post-hoc Lenth’s analysis was performed to ensure adequate sample size.
Fatigability assay
To assess fatigue, a modified negative geotaxis assay was used [30]. For each genotype, 10 un-
anesthetized, sex- and age-matched 5–7 day old adult flies were loaded by aspiration into a 9 cm
tall standard Drosophila vial. Flies were not exposed to CO2 to avoid possible side effects and
were left to acclimate for 1 hour. Experimental and control vials were secured side by side in a
vial rack, raised 6–8 inches above a table, and then dropped, causing all flies to fall to the bottom
of the vial. Vials were dropped every 10 seconds for 30 minutes, and a picture was recorded 5
seconds after every drop. Each picture was analyzed in ImageJ for the distance each fly had trav-
eled up the side of the vial. The average for each sex and genotype was calculated for each pic-
ture, and the data was binned into 1 minute averages. To control for any genotype-dependent
decrease in mobility and thereby specifically assess fatigue, all average distances were normal-
ized to the average distance traveled after the first drop. Linear regressions of the log of the raw
data provided predicted lines of best fit for each sex and genotype. A significant interaction
between time and genotype (for both sexes) in the log of the raw data indicates that there is a
difference between the slopes for the two genotypes. Fitted curves, after back transformation,
are shown in Fig 9. Post-hoc Lenth’s analysis was performed to ensure adequate sample size.
Conclusions
In this study, we investigate the functional role of a synaptotagmin 2 residue implicated in dis-
ease. Recently, a neuromuscular disorder has been reported in which a highly conserved pro-
line residue is mutated to a leucine within synaptotagmin. The functional importance of this
residue was unknown. Here we model the impact of this mutation on the structure of synapto-
tagmin and examine the effects of a homologous mutation in vivo using Drosophila. We found
that this mutation is predicted to produce a conformational change in the C2B domain of
synaptotagmin that would decrease Ca2+ binding. When expressed in flies containing no
synaptotagmin, this mutation was lethal, demonstrating the critical nature of the examined
residue. When expressed in combination with wild type synaptotagmin, we demonstrated a
decreased Ca2+ affinity for neurotransmitter release and a decreased release probability. These
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deficits can account for the defects in neuromuscular function and behavior, which are similar
to those of the human patients. Thus, these results support a role for this amino acid substitu-
tion in human disease etiology.
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